275 related articles for article (PubMed ID: 35976913)
1. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells.
Josan C; Podinic T; Pfaff N; Raha S
PLoS One; 2022; 17(8):e0272819. PubMed ID: 35976913
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
3. Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys.
Carey LM; Maguire DR; France CP
Drug Alcohol Depend; 2023 Mar; 244():109787. PubMed ID: 36753805
[TBL] [Abstract][Full Text] [Related]
4. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.
Chester LA; Englund A; Chesney E; Oliver D; Wilson J; Sovi S; Dickens AM; Oresic M; Linderman T; Hodsoll J; Minichino A; Strang J; Murray RM; Freeman TP; McGuire P
Cannabis Cannabinoid Res; 2024 Feb; 9(1):188-198. PubMed ID: 36493386
[No Abstract] [Full Text] [Related]
5. Individual and combined effects of cannabidiol and Δ
Wall MB; Freeman TP; Hindocha C; Demetriou L; Ertl N; Freeman AM; Jones AP; Lawn W; Pope R; Mokrysz C; Solomons D; Statton B; Walker HR; Yamamori Y; Yang Z; Yim JL; Nutt DJ; Howes OD; Curran HV; Bloomfield MA
J Psychopharmacol; 2022 Jun; 36(6):732-744. PubMed ID: 35596578
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure.
Black T; Baccetto SL; Barnard IL; Finch E; McElroy DL; Austin-Scott FVL; Greba Q; Michel D; Zagzoog A; Howland JG; Laprairie RB
Sci Rep; 2023 Nov; 13(1):21070. PubMed ID: 38030657
[TBL] [Abstract][Full Text] [Related]
7. Δ
Hodges RM; Chase KJ; Tripson MA; Bingham S; Woolley-Roberts M; Guy GW; Soderstrom K
Cannabis Cannabinoid Res; 2023 Oct; 8(5):790-801. PubMed ID: 36125410
[No Abstract] [Full Text] [Related]
8. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.
Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG
Psychopharmacology (Berl); 2022 Nov; 239(11):3731-3741. PubMed ID: 36227352
[TBL] [Abstract][Full Text] [Related]
9. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
10. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of Δ
Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
[TBL] [Abstract][Full Text] [Related]
12. Interactions between cannabidiol and Δ
Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC
Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
[TBL] [Abstract][Full Text] [Related]
14. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.
Freeman TP; Craft S; Wilson J; Stylianou S; ElSohly M; Di Forti M; Lynskey MT
Addiction; 2021 May; 116(5):1000-1010. PubMed ID: 33160291
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol Interferes with Establishment of Δ
DeVuono MV; La Caprara O; Petrie GN; Limebeer CL; Rock EM; Hill MN; Parker LA
Cannabis Cannabinoid Res; 2022 Feb; 7(1):58-64. PubMed ID: 33998876
[No Abstract] [Full Text] [Related]
17. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
18. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV
J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455
[TBL] [Abstract][Full Text] [Related]
19. Effects of a combination of cannabidiol and delta-9-tetrahydrocannabinol on key biological functions of HTR-8/SVneo extravillous trophoblast cells.
Alves P; Amaral C; Teixeira N; Correia-da-Silva G
Toxicology; 2023 Aug; 495():153614. PubMed ID: 37567336
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.
Lawn W; Freeman TP; Pope RA; Joye A; Harvey L; Hindocha C; Mokrysz C; Moss A; Wall MB; Bloomfield MA; Das RK; Morgan CJ; Nutt DJ; Curran HV
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3537-52. PubMed ID: 27585792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
